General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Evaluation of Drug Dependence and the Multifaceted Interpretation of Data

Co-hosted by: Shin Nippon Biomedical Laboratories, Ltd.

In pharmaceutical development, the ICH-M3(R2) guideline (2010) states that the evaluation of drug abuse potential should be considered for CNS-active drugs, regardless of the indication. Furthermore, each of the three major regions—Japan, the United States, and Europe—has its own guidelines on drug dependence and conducts evaluations of drug dependence/abuse potential accordingly. Drug dependence is assessed through multiple studies, each yielding characteristic data. This seminar will introduce the key features and evaluation methods of the guidelines from these three regions and explain the multifaceted interpretation of the characteristic data.

APPW2025

Presentation Information

[2LS05-01]Evaluation of Drug Dependence and the Multifaceted Interpretation of Data

Comment